Related Experiment Video

Updated: Apr 16, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

16.3K

Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment

Bing Feng1, Kai Zhang1, Rui Wang1

  • 1*Department of Medical Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu, China.

Clinical Science (London, England : 1979)
|March 12, 2015
PubMed

Insights

MicroRNAs (miRNAs) play a key role in non-small-cell lung cancer (NSCLC) development and progression. Understanding miRNA functions can lead to new diagnostic biomarkers and personalized therapies for lung cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is a leading cause of cancer mortality globally.
  • Non-small-cell lung cancer (NSCLC) accounts for 80-85% of all lung cancer cases.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.

Purpose of the Study:

  • To review the role of miRNAs in NSCLC pathogenesis.
  • To explore the potential clinical applications of miRNA research in NSCLC.
  • To highlight miRNAs as diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review of studies on miRNA function in NSCLC.
  • Analysis of miRNA-mediated gene regulation in cancer.
  • Discussion of current and future clinical applications of miRNA discoveries.

Main Results:

  • miRNAs are implicated in the development and progression of NSCLC.
  • miRNA dysregulation contributes to various aspects of cancer biology.
  • miRNAs offer potential as biomarkers for early detection and prognosis.

Conclusions:

  • miRNAs are crucial regulators in NSCLC.
  • Further research into miRNAs can yield novel diagnostic and therapeutic strategies for lung cancer.
  • Targeting miRNAs may lead to individualized treatment approaches for NSCLC patients.

More Related Videos

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.8K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K